Skip to content
Recall Observatory FDA recall evidence

Drug product

Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90

D-1211-2018

September 12, 2018

Class III

Product summary

Firm
Hetero Labs, Ltd. - Unit III
Event
Event 81017
Status
Terminated
Classification
Class III
Quantity
5,424 bottles
Official record key
drug-enforcement:D-1211-2018

Official wording

Reason: Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

Code information: Lot #: E181370, Exp. 5/2020

Distribution pattern: Indiana and Louisiana

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablet